Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Remetinostat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medivir Licenses Remetinostat To Biossil In Exclusive Deal
    Medivir Licenses Remetinostat To Biossil In Exclusive Deal

    23 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-23/medivir-enters-exclusive-licensing-agreement-with-biossil-inc-for-remetinostat

    PHARMIWEB
    23 Oct 2025
    Share Share
    Medivir strengthens the business development potential of remetinostat
    Medivir strengthens the business development potential of remetinostat

    16 Aug 2021

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medivir-strengthens-the-business-development-potential-of-remetinostat-through-renegotiated-multi-party-agreement-301355600.html

    PR NEWSWIRE
    16 Aug 2021
    Share Share
    More Remetinostat Ph 2 Data to be Presented at IID Meeting
    More Remetinostat Ph 2 Data to be Presented at IID Meeting

    17 May 2018

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/additional-remetinostat-phase-ii-data-will-be-presented-at-the-international-investigative-dermatology-meeting-on-may-18-and-19-300650893.html

    PRNEWSWIRE
    17 May 2018
    Share Share